Benefit of staying on treatment using drugs that are still active
Even if your viral load is detectable and you are waiting for new drugs, it is better to stay on ART.
Even with drug resistance, it is better to continue to use some meds compared to stopping treatment altogether.
This is especially important if your CD4 count is less than 200.
As long as you are able to tolerate treatment, nukes and PIs are likely to still help.
If you have the key mutations associated with resistance to NNRTIs, T-20 or integrase inhibitors, then there may be no nbenefit from still taking them as they are unlikely to still be active.
Last updated: 1 August 2021.